Skip to main content

Table 1 Peptide candidates for personalized peptide vaccination

From: A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time

Symbol for peptide

Origin protein

Position of peptide

Amino acid sequence

HLA type

CypB-129

Cyclophilin B

129-138

V

A2,A3supa

Lck-246

p56 lck

246-254

KLVERLGAA

A2

Lck-422

p56 lck

422-430

DVWSFGILL

A2,A3sup

MAP-432

ppMAPkkk

432-440

DLLSHAFFA

A2,A26

WHSC2-103

WHSC2

103-111

ASLDSDPWV

A2,A3supa,A26

HNRPL-501

HNRPL

501-510

NVLHFFNAPL

A2,A26

UBE-43

UBE2V

43-51

RLQEWCSVI

A2

UBE-85

UBE2V

85-93

LIADFLSGL

A2

WHSC2-141

WHSC2

141-149

ILGELREKV

A2

HNRPL-140

HNRPL

140-148

ALVEFEDVL

A2

SART3-302

SART3

302-317

LLQAEAPRL

A2

SART3-309

SART3

309-317

RLAEYQAYI

A2

SART2-93

SART2

93-101

DYSARWNEI

A24

SART3-109

SART3

109-118

VYDYNCHVDL

A24,A3supa,A26

Lck-208

p56 lck

208-216

HYTNASDGL

A24

PAP-213

PAP

213-221

LYCESVHNF

A24

PSA-248

PSA

248-257

HYRKWIKDTI

A24

EGFR-800

EGF-R

800-809

DYVREHKDNI

A24

MRP3-503

MRP3

503-511

LYAWEPSFL

A24

MRP3-1293

MRP3

1293-1302

NYSVRYRPGL

A24

SART2-161

SART2

161-169

AYDFLYNYL

A24

Lck-486

p56 lck

486-494

TFDYLRSVL

A24

Lck-488

p56 lck

488-497

DYLRSVLEDF

A24

PSMA-624

PSMA

624-632

TYSVSFDSL

A24

EZH2-735

EZH2

735-743

KYVGIEREM

A24

PTHrP-102

PTHrP

102-111

RYLTQETNKV

A24

SART3-511

SART3

511-519

WLEYYNLER

A3supa

SART3-734

SART3

734-742

QIRPIFSNR

A3supa

Lck-90

p56 lck

90-99

ILEQSGEWWK

A3supa

Lck-449

p56 lck

449-458

VIQNLERGYR

A3supa

PAP-248

PAP

248-257

GIHKQKEKSR

A3supa

  1. aA3sup, HLA-A3 supertype (A3, A11, A31, and A33).